173 related articles for article (PubMed ID: 8523539)
1. Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer.
Martin I; Schaal H; Scheid A; Ruysschaert JM
J Virol; 1996 Jan; 70(1):298-304. PubMed ID: 8523539
[TBL] [Abstract][Full Text] [Related]
2. Correlation between fusogenicity of synthetic modified peptides corresponding to the NH2-terminal extremity of simian immunodeficiency virus gp32 and their mode of insertion into the lipid bilayer: an infrared spectroscopy study.
Martin I; Dubois MC; Defrise-Quertain F; Saermark T; Burny A; Brasseur R; Ruysschaert JM
J Virol; 1994 Feb; 68(2):1139-48. PubMed ID: 8289343
[TBL] [Abstract][Full Text] [Related]
3. Orientation and structure of the NH2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes.
Martin I; Defrise-Quertain F; Decroly E; Vandenbranden M; Brasseur R; Ruysschaert JM
Biochim Biophys Acta; 1993 Jan; 1145(1):124-33. PubMed ID: 8422404
[TBL] [Abstract][Full Text] [Related]
4. Fatty acids can substitute the HIV fusion peptide in lipid merging and fusion: an analogy between viral and palmitoylated eukaryotic fusion proteins.
Lev N; Shai Y
J Mol Biol; 2007 Nov; 374(1):220-30. PubMed ID: 17919659
[TBL] [Abstract][Full Text] [Related]
5. Fusogenic activity of SIV (simian immunodeficiency virus) peptides located in the GP32 NH2 terminal domain.
Martin I; Defrise-Quertain F; Mandieau V; Nielsen NM; Saermark T; Burny A; Brasseur R; Ruysschaert JM; Vandenbranden M
Biochem Biophys Res Commun; 1991 Mar; 175(3):872-9. PubMed ID: 2025261
[TBL] [Abstract][Full Text] [Related]
6. Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended.
Korazim O; Sackett K; Shai Y
J Mol Biol; 2006 Dec; 364(5):1103-17. PubMed ID: 17045292
[TBL] [Abstract][Full Text] [Related]
7. The polar region consecutive to the HIV fusion peptide participates in membrane fusion.
Peisajovich SG; Epand RF; Pritsker M; Shai Y; Epand RM
Biochemistry; 2000 Feb; 39(7):1826-33. PubMed ID: 10677233
[TBL] [Abstract][Full Text] [Related]
8. Effect of cholesterol on the interaction of the HIV GP41 fusion peptide with model membranes. Importance of the membrane dipole potential.
Buzón V; Cladera J
Biochemistry; 2006 Dec; 45(51):15768-75. PubMed ID: 17176099
[TBL] [Abstract][Full Text] [Related]
9. Interaction of fusion peptides from HIV gp41 with membranes: a time-resolved membrane binding, lipid mixing, and structural study.
Buzón V; Padrós E; Cladera J
Biochemistry; 2005 Oct; 44(40):13354-64. PubMed ID: 16201760
[TBL] [Abstract][Full Text] [Related]
10. A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusion.
Pritsker M; Jones P; Blumenthal R; Shai Y
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7287-92. PubMed ID: 9636141
[TBL] [Abstract][Full Text] [Related]
11. The pre-transmembrane region of the human immunodeficiency virus type-1 glycoprotein: a novel fusogenic sequence.
Suárez T; Nir S; Goñi FM; Saéz-Cirión A; Nieva JL
FEBS Lett; 2000 Jul; 477(1-2):145-9. PubMed ID: 10899326
[TBL] [Abstract][Full Text] [Related]
12. Structure and plasticity of the human immunodeficiency virus gp41 fusion domain in lipid micelles and bilayers.
Li Y; Tamm LK
Biophys J; 2007 Aug; 93(3):876-85. PubMed ID: 17513369
[TBL] [Abstract][Full Text] [Related]
13. Conformational mapping of the N-terminal peptide of HIV-1 gp41 in membrane environments using (13)C-enhanced Fourier transform infrared spectroscopy.
Gordon LM; Mobley PW; Pilpa R; Sherman MA; Waring AJ
Biochim Biophys Acta; 2002 Feb; 1559(2):96-120. PubMed ID: 11853678
[TBL] [Abstract][Full Text] [Related]
14. The helix-to-sheet transition of an HIV-1 fusion peptide derivative changes the mechanical properties of lipid bilayer membranes.
Heller WT; Zolnierczuk PA
Biochim Biophys Acta Biomembr; 2019 Mar; 1861(3):565-572. PubMed ID: 30550881
[TBL] [Abstract][Full Text] [Related]
15. Role of the ectodomain of the gp41 transmembrane envelope protein of human immunodeficiency virus type 1 in late steps of the membrane fusion process.
Bär S; Alizon M
J Virol; 2004 Jan; 78(2):811-20. PubMed ID: 14694113
[TBL] [Abstract][Full Text] [Related]
16. The hydrophobic internal region of bovine prion protein shares structural and functional properties with HIV type 1 fusion peptide.
Sáez-Cirión A; Nieva JL; Gallaher WR
AIDS Res Hum Retroviruses; 2003 Nov; 19(11):969-78. PubMed ID: 14678604
[TBL] [Abstract][Full Text] [Related]
17. Fusion activity of HIV gp41 fusion domain is related to its secondary structure and depth of membrane insertion in a cholesterol-dependent fashion.
Lai AL; Moorthy AE; Li Y; Tamm LK
J Mol Biol; 2012 Apr; 418(1-2):3-15. PubMed ID: 22343048
[TBL] [Abstract][Full Text] [Related]
18. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects.
Pereira FB; Goñi FM; Muga A; Nieva JL
Biophys J; 1997 Oct; 73(4):1977-86. PubMed ID: 9336193
[TBL] [Abstract][Full Text] [Related]
19. Effect of the N-terminal glycine on the secondary structure, orientation, and interaction of the influenza hemagglutinin fusion peptide with lipid bilayers.
Gray C; Tatulian SA; Wharton SA; Tamm LK
Biophys J; 1996 May; 70(5):2275-86. PubMed ID: 9172751
[TBL] [Abstract][Full Text] [Related]
20. Membrane-anchored inhibitory peptides capture human immunodeficiency virus type 1 gp41 conformations that engage the target membrane prior to fusion.
Melikyan GB; Egelhofer M; von Laer D
J Virol; 2006 Apr; 80(7):3249-58. PubMed ID: 16537592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
